e.g., HRA000087; HRA000150
  1. Home
  2. Browse
  3. HRA004529
HRA004529
   HRA004529.xlsx
Title:
The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients
Release date:
2023-05-08
Description:
Diagnosis classification and risk stratification are of crucial in the survival prognostication and treatment selection of acute myeloid leukemia (AML). Here, we used a database of 536 AML patients to compare the 4th and 5th WHO, as well as the 2017 and 2022 version of ELN guidance.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA016716
Study type:
Disease Study
Disease name:
acute myeloid leukemia
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC002557
DAC name:
DAC
Contact person:
he pengcheng
Email:
hepc@163.com
Description:
Diagnosis classification and risk stratification are of crucial in the survival prognostication and treatment selection of acute myeloid leukemia (AML). Here, we used a database of 536 AML patients to compare the 4th and 5th WHO, as well as the 2017 and 2022 version of ELN guidance.
Individuals & samples
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
Loading, please wait...
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
No matching records found
Files
Request Data
Run accession
Files
Experiment
Experiment title
Platform
Sample
Loading, please wait...
Run accession
Files
Experiment
Experiment title
Platform
Sample
No matching records found
Submitter:   he pengcheng / hepc@163.com
Organization:   The First Affiliated Hospital of Xi'an Jiaotong University
Submission date:   2023-05-04
Requests:   -